1. Home
  2. ENVB
  3. ENVB News

Latest Enveric Biosciences Inc. (ENVB) News on June 2, 2025

Enveric Biosciences announces results from EB-003 trial
ENVB

TipRanks

4 days ago

Enveric Biosciences announces results from EB-003 trial

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003
ENVB

Business Wire

5 days ago

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease
ENVB

Business Wire

13 days ago

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results
ENVB

Business Wire

19 days ago

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024
ENVB

Business Wire

2 months ago

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

Enveric Biosciences Participating in BIO-Europe Spring®
ENVB

Business Wire

3 months ago

Enveric Biosciences Participating in BIO-Europe Spring®

Enveric Biosciences launches RFP solicitation process for PsyAI trademark
ENVB

TipRanks

3 months ago

Enveric Biosciences launches RFP solicitation process for PsyAI trademark

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
ENVB

Business Wire

3 months ago

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

Psychedelic: GH Research, Compass Pathways report earnings results
ENVB

TipRanks

3 months ago

Psychedelic: GH Research, Compass Pathways report earnings results

Enveric Biosciences CEO Issues Letter to Shareholders
ENVB

Business Wire

3 months ago

Enveric Biosciences CEO Issues Letter to Shareholders

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
ENVB

Business Wire

3 months ago

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
ENVB

Business Wire

4 months ago

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

Enveric Biosciences Announces Closing of $5 Million Public Offering
ENVB

Business Wire

4 months ago

Enveric Biosciences Announces Closing of $5 Million Public Offering

Enveric Biosciences Prices $5 Million Public Offering; Shares Drop 40% in Premarket Trading
ENVB

GuruFocus.com

4 months ago

Enveric Biosciences Prices $5 Million Public Offering; Shares Drop 40% in Premarket Trading

Enveric Biosciences Announces Pricing of $5 Million Public Offering
ENVB

Business Wire

4 months ago

Enveric Biosciences Announces Pricing of $5 Million Public Offering

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office
ENVB

Business Wire

4 months ago

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During "J.P. Morgan Week 2025"
ENVB

Business Wire

5 months ago

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During "J.P. Morgan Week 2025"

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds
ENVB

Business Wire

6 months ago

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior
ENVB

Business Wire

6 months ago

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior

ENVB

Market Exclusive

6 months ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results
ENVB

Business Wire

7 months ago

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002
ENVB

Business Wire

7 months ago

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002

Enveric Biosciences Announces Broad Range of Patent Issuances
ENVB

Business Wire

7 months ago

Enveric Biosciences Announces Broad Range of Patent Issuances

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003
ENVB

Business Wire

8 months ago

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003

Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop
ENVB

Business Wire

8 months ago

Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit
ENVB

Business Wire

8 months ago

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
ENVB

Business Wire

9 months ago

Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries’ License for Treatment of Radiation Dermatitis and Other Conditions
ENVB

Business Wire

10 months ago

Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries’ License for Treatment of Radiation Dermatitis and Other Conditions

Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results
ENVB

Business Wire

10 months ago

Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally
ENVB

Business Wire

10 months ago

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally

Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
ENVB

Business Wire

a year ago

Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement

Enveric Biosciences Announces Patent Granted for Drug Candidate
ENVB

Business Wire

a year ago

Enveric Biosciences Announces Patent Granted for Drug Candidate

Is Enveric Biosciences, Inc. (NASDAQ:ENVB) Trading At A 36% Discount?
ENVB

Simply Wall St.

a year ago

Is Enveric Biosciences, Inc. (NASDAQ:ENVB) Trading At A 36% Discount?

ENVB

GlobeNewswire

a year ago

Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
ENVB

Business Wire

a year ago

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate

ENVB

Journal-News, Hamilton, Ohio

a year ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs
ENVB

TechCrunch

a year ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now
ENVB

Motley Fool

a year ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Italian energy company targets Britain for fleet of 20 mini-nukes
ENVB

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
ENVB

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners
ENVB

Bloomberg

a year ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
ENVB

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
ENVB

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Enveric Biosciences to Participate in BIO International Convention 2024
ENVB

Business Wire

a year ago

Enveric Biosciences to Participate in BIO International Convention 2024

ENVB

Market Exclusive

a year ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results
ENVB

Business Wire

a year ago

Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
ENVB

Business Wire

a year ago

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders

Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
ENVB

Business Wire

a year ago

Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
ENVB

Business Wire

a year ago

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
ENVB

Business Wire

a year ago

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease

Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets
ENVB

Business Wire

a year ago

Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
ENVB

Business Wire

a year ago

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds

ENVB

GlobeNewswire

a year ago

CORRECTION – Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)

Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
ENVB

Business Wire

a year ago

Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property

Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders
ENVB

Business Wire

a year ago

Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders

Mullen Opens Dominican Republic and Caribbean Markets for Commercial EVs
ENVB

GlobeNewswire

a year ago

Mullen Opens Dominican Republic and Caribbean Markets for Commercial EVs

Has Optex Systems Holdings, Inc's (NASDAQ:OPXS) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
ENVB

Simply Wall St.

a year ago

Has Optex Systems Holdings, Inc's (NASDAQ:OPXS) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

ENVB

Business Wire

a year ago

Cherry Hill Mortgage Investment Corporation Announces Taxable Composition of 2023 Dividends

J.V.B. Financial Group, LLC Hires George Holstead to Expand Middle Markets Group
ENVB

GlobeNewswire

a year ago

J.V.B. Financial Group, LLC Hires George Holstead to Expand Middle Markets Group

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split
ENVB

GlobeNewswire

a year ago

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split

Energous Announces Change of Chief Financial Officer
ENVB

Business Wire

a year ago

Energous Announces Change of Chief Financial Officer

SYLA Technologies Became the Largest Shareholder of RIBERESUTE by Acquiring 20.39% of its Shares
ENVB

GlobeNewswire

a year ago

SYLA Technologies Became the Largest Shareholder of RIBERESUTE by Acquiring 20.39% of its Shares

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting
ENVB

GlobeNewswire

a year ago

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

Banzai Unveils 2024 Webinar Insights Guide: The Must-Have Resource for Marketers Seeking Successful Webinar Strategies
ENVB

GlobeNewswire

a year ago

Banzai Unveils 2024 Webinar Insights Guide: The Must-Have Resource for Marketers Seeking Successful Webinar Strategies

17EdTech Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
ENVB

GlobeNewswire

a year ago

17EdTech Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
ENVB

Business Wire

a year ago

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

Fossil Taps Tangiblee for ‘First of Its Kind’ Virtual Try-on Experience
ENVB

WWD

a year ago

Fossil Taps Tangiblee for ‘First of Its Kind’ Virtual Try-on Experience

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer
ENVB

GlobeNewswire

a year ago

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings
ENVB

Simply Wall St.

a year ago

Better Therapeutics Insiders Added US$6.57m Of Stock To Their Holdings

Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
ENVB

Business Wire

a year ago

Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024
ENVB

GlobeNewswire

a year ago

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024

ENVB

Business Wire

a year ago

Enveric Biosciences Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.8 Million Gross Proceeds Priced At-the-Market

Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series
ENVB

Business Wire

a year ago

Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series

Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373
ENVB

Business Wire

a year ago

Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373

Analysts Say 3 Stocks Have a Combined Upside of 3000%
ENVB

InvestorPlace

a year ago

Analysts Say 3 Stocks Have a Combined Upside of 3000%

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on December 29, 2023 at 10:00 a.m. Eastern Time
ENVB

GlobeNewswire

a year ago

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on December 29, 2023 at 10:00 a.m. Eastern Time

United Nations High Commissioner for Refugees Awards Polar Power Initial Contract to Assure Uninterrupted Quality Electric Power for African Offices
ENVB

GlobeNewswire

a year ago

United Nations High Commissioner for Refugees Awards Polar Power Initial Contract to Assure Uninterrupted Quality Electric Power for African Offices

Enveric Biosciences to Participate in Biotech Showcase 2024 During "J.P. Morgan Week 2024"
ENVB

Business Wire

a year ago

Enveric Biosciences to Participate in Biotech Showcase 2024 During "J.P. Morgan Week 2024"

ENVB

Business Wire

a year ago

Cherry Hill Mortgage Investment Corporation Authorizes Preferred Stock Repurchase Program

EMCORE Corporation (NASDAQ:EMKR) Shares Could Be 48% Below Their Intrinsic Value Estimate
ENVB

Simply Wall St.

a year ago

EMCORE Corporation (NASDAQ:EMKR) Shares Could Be 48% Below Their Intrinsic Value Estimate

ENVB

Business Wire

a year ago

Cherry Hill Mortgage Investment Corporation Announces Common and Preferred Dividends for the Fourth Quarter 2023

Enveric Biosciences Selects Development Candidates from EVM301 Series Based on Potential to Minimize or Eliminate the Hallucinogenic Effect of Psychedelic-Derived Compounds
ENVB

Business Wire

a year ago

Enveric Biosciences Selects Development Candidates from EVM301 Series Based on Potential to Minimize or Eliminate the Hallucinogenic Effect of Psychedelic-Derived Compounds

Fusion Fuel Green Hosts Third Quarter 2023 Investor Update
ENVB

GlobeNewswire

a year ago

Fusion Fuel Green Hosts Third Quarter 2023 Investor Update

Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives
ENVB

Business Wire

2 years ago

Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives

11 Cheapest Stocks With Biggest Upside
ENVB

Insider Monkey

2 years ago

11 Cheapest Stocks With Biggest Upside

Enveric Biosciences Announces Manuscript Describing the Development of Lead Product Candidate, EB-373, to be Featured on the Cover of the Journal of Medicinal Chemistry
ENVB

Business Wire

2 years ago

Enveric Biosciences Announces Manuscript Describing the Development of Lead Product Candidate, EB-373, to be Featured on the Cover of the Journal of Medicinal Chemistry

7 Under-$10 Names to Put in Your Christmas Stocking
ENVB

InvestorPlace

2 years ago

7 Under-$10 Names to Put in Your Christmas Stocking

Implied Volatility Surging for On trivago (TRVG) Stock Options
ENVB

Zacks

2 years ago

Implied Volatility Surging for On trivago (TRVG) Stock Options

5 REITs Under $5 Making Huge Gains This Month
ENVB

Benzinga

2 years ago

5 REITs Under $5 Making Huge Gains This Month

ENVB

Zacks Small Cap Research

2 years ago

SDOT: Sadot Group reports 3rd quarter operating results which showed continued high levels of revenue generation in the core agri-foods subsidiary.

Janover Announces Share Repurchase Program
ENVB

GlobeNewswire

2 years ago

Janover Announces Share Repurchase Program

Castor Maritime Inc. Announces the Completion of the Sale of the M/V Magic Sun
ENVB

GlobeNewswire

2 years ago

Castor Maritime Inc. Announces the Completion of the Sale of the M/V Magic Sun

Sadot Group Inc. Reports Third Quarter 2023 Results
ENVB

ACCESSWIRE

2 years ago

Sadot Group Inc. Reports Third Quarter 2023 Results

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
ENVB

GlobeNewswire

2 years ago

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

aTyr Pharma's Market Cap Drops To US$66m Leaving Insiders With Losses
ENVB

Simply Wall St.

2 years ago

aTyr Pharma's Market Cap Drops To US$66m Leaving Insiders With Losses

Optex Systems Announces $1.3 Million Order for Laser Filter Units
ENVB

ACCESSWIRE

2 years ago

Optex Systems Announces $1.3 Million Order for Laser Filter Units

The Dixie Group 2023 Q3 Earnings Release and Conference Call
ENVB

ACCESSWIRE

2 years ago

The Dixie Group 2023 Q3 Earnings Release and Conference Call

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
ENVB

GlobeNewswire

2 years ago

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

Team Inc. Names Michael Caliel as Executive Chairman
ENVB

Hart Energy

2 years ago

Team Inc. Names Michael Caliel as Executive Chairman

Charge Enterprises Reports Third Quarter 2023 Financial Results
ENVB

Business Wire

2 years ago

Charge Enterprises Reports Third Quarter 2023 Financial Results

Share on Social Networks: